ThetaPal ThetaPal

Manufacturing / Biological Products, Except Diagnostic Substances

Maze Therapeutics, Inc.

MAZE

$26.69

+$0.83 (+3.20%)

Price as of Oct 9, 2026 16:32 UTC

1.7 B

Market Cap (Small Cap)

Nov 02

Next Earnings

Technical Signals as of Oct 7
Bearish
1 of 7

Trend

  • Above 20-day average $26.27
  • Above 50-day average $26.74
  • Above 200-day average $31.11 · -15.6%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) Down · 25d ago

Volume

  • Below-average volume 0.9x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Heat Map

Delta-risk grid for MAZE options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 96 sells
Date Insider Title Type Shares Value Since Trade
Oct 01, 2026 Coloma Jason V Sell 31,908 $862,186 -4.2%
Oct 01, 2026 Bernstein Harold Exercise 16,141 $168,189 +148.4%
Oct 01, 2026 Bernstein Harold Exercise 16,141 $0 -2.9%
Oct 01, 2026 Bernstein Harold Sell 16,141 $434,743 -3.9%
Oct 01, 2026 Coloma Jason V Sell 2,593 $70,073 -4.2%
Sep 29, 2026 Dandekar Atul Exercise 7,500 $0 -4.2%
Sep 29, 2026 Dandekar Atul Sell 7,500 $202,921 -4.3%
Sep 29, 2026 Dandekar Atul Exercise 7,500 $78,150 +148.4%
Sep 04, 2026 Bernstein Harold Sell 9,705 $254,502 -1.3%
Sep 03, 2026 Coloma Jason V Sell 11,282 $293,482 -0.5%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 18, 2026 Q2 2026 -$0.75
Mar 31, 2026 Q1 2026 -$0.56 -$0.45 +19.1% Beat
Dec 31, 2025 Q4 2025 -$0.73 -$0.65 +10.7% Beat
Sep 30, 2025 Q3 2025 -$0.72 -$0.66 +8.7% Beat
Jun 30, 2025 Q2 2025 -$0.87 -$0.77 +11.8% Beat

Track MAZE with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for MAZE and your entire portfolio.